Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine, Seoul, Korea.
Department of Pathology, Yonsei University College of Medicine, Seoul, Korea.
Thorac Cancer. 2021 May;12(10):1605-1612. doi: 10.1111/1759-7714.13960. Epub 2021 Apr 3.
Although perineural invasion is a well known prognostic factor used in several cancers, its prognostic role in esophageal squamous cell carcinoma remains controversial. Here, we investigated the prognostic role of perineural invasion in surgically treated esophageal squamous cell carcinoma.
We retrospectively reviewed the medical records of 316 patients who underwent esophagectomy and lymph node dissection for esophageal squamous cell carcinoma between 2007 and 2016.
Overall, 287 men (mean age: 62.73 ± 7.97 years) were included in the study. The median follow-up period was 35.97 ± 30.99 months, perineural invasion was confirmed in 25 patients, and three-year overall and disease-free survival were significantly lower in the perineural invasion group than in the no-perineural invasion group (75.9% vs. 40.0%, p < 0.001; 70.3% vs. 21.6%, p < 0.001). Cumulative incidences of locoregional recurrence and distant metastasis over three years were higher in the perineural invasion group (13.8% vs. 9.6%, p = 0.009 and 52.8% vs. 14.6%, p < 0.001). On performing multivariable analysis, perineural invasion, pathological stage, incomplete resection, and neoadjuvant therapy were adverse risk factors for disease-free survival. The concordance index increased when perineural invasion was included in the model (0.712 vs. 0.723). On subgroup analysis, perineural invasion demonstrated a prognostic value in node-negative patients (79.4% vs. 35.7%, p = 0.012).
Perineural invasion was found to be an adverse risk factor for disease-free survival in surgically treated patients with esophageal squamous cell carcinoma. Close observation and individualized adjuvant therapy may be helpful for patients with perineural invasion.
尽管神经周围侵犯是几种癌症中众所周知的预后因素,但它在食管鳞状细胞癌中的预后作用仍存在争议。在这里,我们研究了神经周围侵犯在接受手术治疗的食管鳞状细胞癌患者中的预后作用。
我们回顾性分析了 2007 年至 2016 年间接受食管癌根治术和淋巴结清扫术的 316 例食管鳞状细胞癌患者的病历。
共有 287 例男性(平均年龄:62.73±7.97 岁)纳入本研究。中位随访时间为 35.97±30.99 个月,25 例患者被证实存在神经周围侵犯,神经周围侵犯组的 3 年总生存率和无病生存率明显低于无神经周围侵犯组(75.9%比 40.0%,p<0.001;70.3%比 21.6%,p<0.001)。神经周围侵犯组 3 年内局部区域复发和远处转移的累积发生率更高(13.8%比 9.6%,p=0.009 和 52.8%比 14.6%,p<0.001)。多变量分析显示,神经周围侵犯、病理分期、不完全切除和新辅助治疗是无病生存的不良危险因素。当将神经周围侵犯纳入模型时,一致性指数增加(0.712 比 0.723)。亚组分析显示,神经周围侵犯在淋巴结阴性患者中具有预后价值(79.4%比 35.7%,p=0.012)。
神经周围侵犯是接受手术治疗的食管鳞状细胞癌患者无病生存的不良危险因素。密切观察和个体化辅助治疗可能对神经周围侵犯的患者有帮助。